IS4569A - Bensamíð til að meðhöndla taugahrörnunarsjúkdóma - Google Patents

Bensamíð til að meðhöndla taugahrörnunarsjúkdóma

Info

Publication number
IS4569A
IS4569A IS4569A IS4569A IS4569A IS 4569 A IS4569 A IS 4569A IS 4569 A IS4569 A IS 4569A IS 4569 A IS4569 A IS 4569A IS 4569 A IS4569 A IS 4569A
Authority
IS
Iceland
Prior art keywords
benzamide
treatment
neurodegenerative disorders
neurodegenerative
disorders
Prior art date
Application number
IS4569A
Other languages
English (en)
Other versions
IS1919B (is
Inventor
David Flitter William
A. Garland William
L. Wilcox Allan
E. Paylor Richard
Original Assignee
Renovis, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/415,694 external-priority patent/US5658953A/en
Priority claimed from US08/415,847 external-priority patent/US5643965A/en
Priority claimed from US08/415,248 external-priority patent/US5659082A/en
Application filed by Renovis, Inc. filed Critical Renovis, Inc.
Publication of IS4569A publication Critical patent/IS4569A/is
Publication of IS1919B publication Critical patent/IS1919B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS4569A 1995-04-03 1997-09-25 Bensamíð til að meðhöndla taugahrörnunarsjúkdóma IS1919B (is)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41567795A 1995-04-03 1995-04-03
US08/415,694 US5658953A (en) 1995-04-03 1995-04-03 Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US08/415,847 US5643965A (en) 1995-04-03 1995-04-03 Aminobenzamide compounds for the treatment of neurodegenerative disorders
US08/415,248 US5659082A (en) 1995-04-03 1995-04-03 Nitro- and aminobenzamide compounds for neurodegenerative disorders
PCT/US1996/004538 WO1996031462A1 (en) 1995-04-03 1996-04-03 Benzamides for neurodegenerative disorder treatment

Publications (2)

Publication Number Publication Date
IS4569A true IS4569A (is) 1997-09-25
IS1919B IS1919B (is) 2004-03-15

Family

ID=27503636

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4569A IS1919B (is) 1995-04-03 1997-09-25 Bensamíð til að meðhöndla taugahrörnunarsjúkdóma

Country Status (39)

Country Link
EP (1) EP0819113B1 (is)
JP (1) JP3479658B2 (is)
KR (1) KR100429120B1 (is)
CN (1) CN1073552C (is)
AR (1) AR002978A1 (is)
AT (1) ATE202552T1 (is)
AU (1) AU721045B2 (is)
BG (1) BG63384B1 (is)
CA (1) CA2215166A1 (is)
CO (1) CO4700431A1 (is)
CZ (1) CZ295852B6 (is)
DE (1) DE69613567T2 (is)
DK (1) DK0819113T3 (is)
DZ (1) DZ2012A1 (is)
EA (1) EA002031B1 (is)
EE (1) EE03437B1 (is)
ES (1) ES2160240T3 (is)
GR (1) GR3036466T3 (is)
HK (1) HK1016964A1 (is)
HR (1) HRP960156B1 (is)
HU (1) HUP9801759A3 (is)
IL (1) IL117629A (is)
IS (1) IS1919B (is)
MA (1) MA23837A1 (is)
MX (1) MX9707596A (is)
MY (1) MY121206A (is)
NO (1) NO318441B1 (is)
NZ (1) NZ306204A (is)
PL (1) PL184121B1 (is)
PT (1) PT819113E (is)
RO (1) RO116190B1 (is)
SA (1) SA96160739B1 (is)
SI (1) SI0819113T1 (is)
SK (1) SK282900B6 (is)
TN (1) TNSN96051A1 (is)
TR (1) TR199701114T1 (is)
TW (1) TW381073B (is)
WO (1) WO1996031462A1 (is)
YU (1) YU21096A (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW412421B (en) * 1996-04-17 2000-11-21 Centaur Pharmaceuticals Inc Benzamide treatment of dementia associated with AIDS virus (HIV-1) infection
EP1034783B1 (en) * 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
US6271265B1 (en) 1998-05-19 2001-08-07 Centaur Pharmaceuticals, Inc. Amide therapeutics for the treatment of inflammatory bowel disease
EP1079820A1 (en) * 1998-05-19 2001-03-07 Centaur Pharmaceuticals, Inc. Benzamide therapeutics for the treatment of inflammatory bowel disease
WO2000064430A1 (fr) * 1999-04-23 2000-11-02 Sumitomo Pharmaceuticals Co., Ltd. Inhibiteurs de l'apoptose
CN101817761B (zh) * 2010-01-29 2014-06-25 浙江大学 苯甲酸酯类衍生物及制备方法和应用
US9206125B2 (en) 2010-02-10 2015-12-08 Public University Corporation Yokohama City University Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease
CN115594603A (zh) * 2022-10-09 2023-01-13 湖北师范大学(Cn) 微通道反应器制备n-叔丁基-4-氨基苯甲酰胺的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1069882B (it) * 1975-12-22 1985-03-25 Mallinckrodt Inc 3 5 bis acilammino benzammidi particolarmente utili come agenti di contrasto per raffi x e procedimento per la loro preparazione
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent
JPS5867657A (ja) * 1981-10-15 1983-04-22 Chugai Pharmaceut Co Ltd ペンズアミド誘導体
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
CO4700431A1 (es) 1998-12-29
EE9700235A (et) 1998-04-15
DE69613567D1 (de) 2001-08-02
AU721045B2 (en) 2000-06-22
JP3479658B2 (ja) 2003-12-15
PL184121B1 (pl) 2002-09-30
TW381073B (en) 2000-02-01
YU21096A (sh) 1999-03-04
CN1073552C (zh) 2001-10-24
IS1919B (is) 2004-03-15
EP0819113B1 (en) 2001-06-27
EE03437B1 (et) 2001-06-15
ATE202552T1 (de) 2001-07-15
GR3036466T3 (en) 2001-11-30
IL117629A (en) 2000-08-13
EA002031B1 (ru) 2001-12-24
DZ2012A1 (fr) 2002-07-21
HUP9801759A2 (hu) 1998-12-28
KR100429120B1 (ko) 2004-08-18
HRP960156B1 (en) 2002-04-30
AU5440496A (en) 1996-10-23
ES2160240T3 (es) 2001-11-01
MX9707596A (es) 1998-06-30
BG63384B1 (bg) 2001-12-29
WO1996031462A1 (en) 1996-10-10
JPH11501319A (ja) 1999-02-02
HUP9801759A3 (en) 2001-06-28
PL322625A1 (en) 1998-02-02
TR199701114T1 (xx) 1998-02-21
NO318441B1 (no) 2005-03-21
CN1182416A (zh) 1998-05-20
SK132597A3 (en) 1998-09-09
EA199700287A1 (ru) 1998-04-30
SK282900B6 (sk) 2003-01-09
MA23837A1 (fr) 1996-12-31
BG101929A (en) 1998-04-30
KR19980703562A (ko) 1998-11-05
CA2215166A1 (en) 1996-10-10
NO974569L (no) 1997-11-21
HRP960156A2 (en) 1997-10-31
PT819113E (pt) 2001-10-30
TNSN96051A1 (fr) 2005-03-15
HK1016964A1 (en) 1999-11-12
EP0819113A1 (en) 1998-01-21
AR002978A1 (es) 1998-05-27
NO974569D0 (no) 1997-10-02
SI0819113T1 (en) 2001-10-31
CZ295852B6 (cs) 2005-11-16
DK0819113T3 (da) 2001-10-15
NZ306204A (en) 1999-01-28
SA96160739B1 (ar) 2005-10-15
DE69613567T2 (de) 2002-04-18
CZ309897A3 (cs) 1998-12-16
IL117629A0 (en) 1996-07-23
MY121206A (en) 2006-01-28
RO116190B1 (ro) 2000-11-30

Similar Documents

Publication Publication Date Title
PT966436E (pt) Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
ATE231724T1 (de) Kombinationstherapie für die behandlung von psychosen
DK0861081T3 (da) Anvendelse af epinastin til behandling af smerter
IL121170A0 (en) Compositions for the treatment of dermatological disorders
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
TR199600481A2 (tr) Tedavi edici amidler.
ITMI951746A0 (it) Dispositivo per il trattamento di dispersioni
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS4569A (is) Bensamíð til að meðhöndla taugahrörnunarsjúkdóma
EE200000391A (et) Triasiiniühendid kesknärvisüsteemihäirete raviks
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte
DE68909304T2 (de) Aminosäuren für der Behandung neurodegenerativer Störungen.
FI952953A0 (fi) Aineita metabolisten luustosairauksien hoitamiseen
NO953089L (no) Steroider for behandling av klimakterieplager
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO962385L (no) Terapeutiske amider
KR970020846U (ko) 근골격계질환 치료보조용 반창고
UA25221A (uk) Спосіб лікуваhhя розладів цеhтральhої hервової системи
KR970012147U (ko) 팔찌용 지압구
FI953860A0 (fi) Yhdistelmäpalkki
KR970020845U (ko) 근골격계질환 치료보조용 테이프
DK82798A (da) Treatment of GABA-uptake related disorders